Literature DB >> 1552710

Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.

A Blumberg1, P Weidmann, P Ferrari.   

Abstract

In hemodialysis patients with hyperkalemia, i.v. sodium bicarbonate has recently been found to be ineffective in lowering plasma potassium within one hour. In the present study the effect of a prolonged bicarbonate infusion on plasma potassium was investigated. Twelve patients with terminal renal failure who were on hemodialysis were infused i.v. with 8.4% sodium bicarbonate (4 mmol/min) for one hour and with 1.4% (0.5 mmol/min) for five hours (total amount 390 mmol). Plasma bicarbonate rose from 17.5 at baseline to 28.4 and 29.6 mmol/liter, and blood pH from 7.32 to 7.46 and 7.48 at one and six hours, respectively. Plasma potassium did not change significantly after one and two hours (6.04 at baseline, 5.91 and 5.77 mmol/liter, respectively). Only at four and six hours did a moderate decline to 5.44 (P less than 0.05) and to 5.30 (P less than 0.01) occur, of which approximately half was calculated to be due to ECF volume expansion. However, no change or a very moderate decrease was observed in three patients even after six hours (+0.19, -0.32, -0.33 mmol/liter). Five patients with higher baseline plasma potassium (6.15 to 8.15 mmol/liter) behaved like seven with lower levels (5.25 to 5.87 mmol/liter). Tented T-waves in the ECG of seven patients disappeared after one hour only in one patient. Plasma aldosterone, norepinephrine and epinephrine were normal to elevated before and tended to fall during i.v. bicarbonate. Plasma dopamine and insulin were in the normal range.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552710     DOI: 10.1038/ki.1992.51

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  Pathogenesis, diagnosis and management of hyperkalemia.

Authors:  Anja Lehnhardt; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2010-12-22       Impact factor: 3.714

Review 2.  Pathogenesis and treatment of dyskalemia in maintenance hemodialysis and CAPD.

Authors:  Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2006-03

3.  Effects of pH on potassium: new explanations for old observations.

Authors:  Peter S Aronson; Gerhard Giebisch
Journal:  J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 10.121

Review 4.  Hyperkalemia revisited.

Authors:  Walter A Parham; Ali A Mehdirad; Kurt M Biermann; Carey S Fredman
Journal:  Tex Heart Inst J       Date:  2006

5.  Treatment of hyperkalemic emergencies.

Authors:  Yao Wu; Yang-Yang Fu; Hua-Dong Zhu; Jun Xu; Joseph Harold Walline
Journal:  World J Emerg Med       Date:  2022

6.  Renal Failure Patients in Disasters.

Authors:  Kenneth D Lempert; Jeffrey B Kopp
Journal:  Disaster Med Public Health Prep       Date:  2019-05-06       Impact factor: 1.385

Review 7.  Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients?

Authors:  David E St-Jules; David S Goldfarb; Mary Ann Sevick
Journal:  J Ren Nutr       Date:  2016-03-12       Impact factor: 3.655

8.  Potassium-Binding Agents for the Clinical Management of Hyperkalemia.

Authors:  Martin Chaitman; Deepali Dixit; Mary Barna Bridgeman
Journal:  P T       Date:  2016-01

Review 9.  Potassium homeostasis and its disturbances in children.

Authors:  J Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

10.  A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.

Authors:  Stephen R Ash; Bhupinder Singh; Philip T Lavin; Fiona Stavros; Henrik S Rasmussen
Journal:  Kidney Int       Date:  2015-02-04       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.